GeoWealth Management LLC Has $306,000 Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

GeoWealth Management LLC lowered its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 42.9% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 515 shares of the biotechnology company’s stock after selling 387 shares during the period. GeoWealth Management LLC’s holdings in Axon Enterprise were worth $306,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Friedenthal Financial raised its holdings in shares of Axon Enterprise by 961.7% during the 4th quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company’s stock valued at $808,000 after purchasing an additional 1,231 shares in the last quarter. Principal Financial Group Inc. raised its holdings in Axon Enterprise by 33.1% during the third quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company’s stock valued at $54,466,000 after buying an additional 33,869 shares in the last quarter. Artemis Investment Management LLP lifted its position in shares of Axon Enterprise by 21.4% in the fourth quarter. Artemis Investment Management LLP now owns 95,113 shares of the biotechnology company’s stock worth $56,528,000 after buying an additional 16,792 shares during the last quarter. Decker Retirement Planning Inc. bought a new stake in shares of Axon Enterprise during the 4th quarter worth about $2,985,000. Finally, MRA Advisory Group increased its holdings in shares of Axon Enterprise by 64.4% during the 4th quarter. MRA Advisory Group now owns 3,205 shares of the biotechnology company’s stock valued at $1,905,000 after acquiring an additional 1,255 shares during the last quarter. Institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Up 2.5 %

AXON opened at $555.52 on Wednesday. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99. The company has a market capitalization of $42.57 billion, a P/E ratio of 143.55, a P/E/G ratio of 5.17 and a beta of 1.13. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The firm’s fifty day moving average price is $551.62 and its two-hundred day moving average price is $568.27.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on AXON shares. The Goldman Sachs Group boosted their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. JMP Securities reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. TD Cowen assumed coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price for the company. Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 19th. Finally, Barclays reissued a “hold” rating on shares of Axon Enterprise in a research report on Monday, March 10th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $626.45.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, Director Jeri Williams sold 307 shares of Axon Enterprise stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $552.72, for a total transaction of $169,685.04. Following the sale, the director now directly owns 1,627 shares of the company’s stock, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.